<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03977428</url>
  </required_header>
  <id_info>
    <org_study_id>2019LMC-1</org_study_id>
    <nct_id>NCT03977428</nct_id>
  </id_info>
  <brief_title>Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study</brief_title>
  <acronym>CHD-PAHCS</acronym>
  <official_title>Central China Congenital Heart Disease Associated Pulmonary Arterial Hypertension Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Wuhan Asia Heart Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Wuhan Asia Heart Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study will recruit and follow up patients for five years patients newly diagnosed with
      congenital heart disease associated pulmonary arterial hypertension(CHD-PAH) from the
      investigator's hospital. The main aim of the study is to describe the aetiology, natural
      history and management practices of CHD-PAH in central China.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      baseline include: An echocardiogram to assess the size, shape, pumping action and the extent
      of any damage to the heart.

      Lung function tests which include blowing measurements to assess gas volumes within the lungs
      as well as assessment of how the lungs exchange gases.

      Right heart catheterisation (RHC) to diagnose PAH Optional Cardiac Magnetic Resonance tests.
      6 minute walk distance (6MWD). To measure exercise capacity Electrocardiogram (ECG), a test
      that measures the electrical activity of the heart Blood tests

      main outcome measure include:

      death heart/lung transplantation atrial septostomy hospitalization due to worsening of PAH
      start of new specific PAH treatment persistent decrease of &gt;15% from baseline in 6MWD (or
      &gt;30% compared with last study-related measurement) persistent worsening of World Health
      Organization (WHO) Functional Class (FCï¼‰
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2019</start_date>
  <completion_date type="Anticipated">June 30, 2023</completion_date>
  <primary_completion_date type="Anticipated">December 30, 2022</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>survival</measure>
    <time_frame>5 years</time_frame>
    <description>To recruit a cohort of CHD-PAH cases. define the death as the primary outcome</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>clinical worsening</measure>
    <time_frame>5 years</time_frame>
    <description>one of the following: death, heart/lung transplantation, atrial septostomy, hospitalization due to worsening of PAH, start of new specific PAH treatment, persistent decrease of &gt;15% from baseline in 6MWD (or &gt;30% compared with last study-related measurement), persistent worsening of WHO FC</description>
  </secondary_outcome>
  <enrollment type="Anticipated">500</enrollment>
  <condition>Pulmonary Arterial Hypertension</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>standard of care</intervention_name>
    <description>No intervention, this a patient registry and is purely an observational study</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        patients with diagnosis of CHD-PAH
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        Diagnosis of CHD-PAH (by RHC)

        Exclusion Criteria:

        Refusal to participate.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>1 Year</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Qiu Qiu</last_name>
    <role>Principal Investigator</role>
    <affiliation>Wuhan Asian Heart Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Zheng Xuan</last_name>
    <phone>+8618627885144</phone>
    <email>soniazheng@outlook.com</email>
  </overall_contact>
  <location>
    <facility>
      <name>Wuhan Asian Heart Hospital</name>
      <address>
        <city>Wuhan</city>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Qiu qiu</last_name>
    </contact>
    <investigator>
      <last_name>Zhang gangcheng</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>June 2019</verification_date>
  <study_first_submitted>June 4, 2019</study_first_submitted>
  <study_first_submitted_qc>June 5, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">June 6, 2019</study_first_posted>
  <last_update_submitted>June 5, 2019</last_update_submitted>
  <last_update_submitted_qc>June 5, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 6, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Familial Primary Pulmonary Hypertension</mesh_term>
    <mesh_term>Hypertension</mesh_term>
    <mesh_term>Heart Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

